Vetmedin Ca1 is a drug owned by BOEHRINGER LNGELHEIM ANIMAL HEALTH USA, INC. It is protected by 7 US drug patents filed from 2025 to 2037. Out of these, 4 patents are active and 3 patents have expired. Details of Vetmedin Ca1’s patents and their expiration are given below.
| Drug Patent Number | Drug Patent Expiry | Status |
|---|---|---|
 | ||
| US8846679 | 23 Jun, 2027 | Active |
| US8980894 | 12 Apr, 2026 | Active |
| US10537588 | 23 Mar, 2025 | Expired |
| US11413285 | 23 Mar, 2025 | Expired |
| US8859554 | 04 Mar, 2025 | Expired |
About Vetmedin Ca1
Vetmedin Ca1 is a drug
owned by BOEHRINGER LNGELHEIM ANIMAL HEALTH USA, INC.
Vetmedin Ca1 uses
Pimobendan as the active
ingredient.
Active Ingredient:
Vetmedin Ca1 uses
Pimobendan as the active ingredient.
Check out other Drugs and Companies using
Pimobendan ingredient.